Deciphering age-specific molecular features in cervical cancer and constructing an angio-immune prognostic model DOI Creative Commons
Xin Zhao,

Xichen Fan,

Lin Xiu

и другие.

Medicine, Год журнала: 2024, Номер 103(15), С. e37717 - e37717

Опубликована: Апрель 12, 2024

Cancer incidence is increasingly seen in younger individuals. Molecular distinctions between young and elderly patients at onset are understudied. This study used public databases to explore genomic, transcriptomic, immune-related features across age groups cervical cancer. Additionally, it aims create a prognostic model applicable diverse cohorts, enabling precise patient stratification, personalized therapies. Gene mutations, expression data, clinicopathological information were obtained from 317 cancer patients. These divided into group an old based on the median of onset. The characteristics differential gene mutation, expression, immune cells analysis analyzed by R software. Finally, was constructed univariate Cox, least absolute shrinkage selection operator, multivariate Cox regression analyses angiogenic sets. Its validity further confirmed using additional 300 squamous cell carcinoma endocervical adenocarcinoma tissues. Cervical exhibit significantly higher frequency NOTCH1 TP53 driver mutations compared patients, along with notably tumor mutational burden. However, there no significant differences 2 terms genomic instability age-related signatures. Differential revealed that upregulated interferon-alpha gamma responses exhibited activity multiple metabolic pathways. Immune microenvironment indicated enrichment dendritic natural killer group, while transforming growth factor-β signature enriched indicating degree exclusion. A multigene angiogenesis T sets showed excellent performance independent clinical factors such as age. High-risk identified activation tumor-promoting processes, metastasis angiogenesis. Our reveals distinct patterns cancer-driving mechanisms, biological system status findings shed light age-specific underlying mechanisms carcinogenesis. Furthermore, molecular provide valuable references for stratification development potential drug targets.

Язык: Английский

Advances in dendritic cell vaccination therapy of cancer DOI Open Access
Sajad Najafi, Keywan Mortezaee

Biomedicine & Pharmacotherapy, Год журнала: 2023, Номер 164, С. 114954 - 114954

Опубликована: Май 29, 2023

Traditionally, vaccines have helped eradication of several infectious diseases and also saved millions lives in the human history. Those prophylactic acted through inducing immune responses against a live attenuated, killed organism or antigenic subunits to protect recipient real infection caused by pathogenic microorganism. Nevertheless, development anticancer as valuable targets health has faced challenges requires further optimizations. Dendritic cells (DCs) are most potent antigen presenting (APCs) that play essential roles tumor immunotherapies induction CD8+ T cell immunity. Accordingly, various strategies been tested employ DCs therapeutic for exploiting their activity cells. Application whole purified/recombinant peptides common approaches pulsing DCs, which then injected back into patients. Although some hopeful results reported number DC animal clinical trials cancer patients, such still inefficient require optimization. Failure vaccination is postulated due immunosuppressive microenvironment (TME), overexpression checkpoint proteins, suboptimal avidity tumor-associated (TAA)-specific lymphocytes, lack appropriate adjuvants. In this review, we an overview current experiments evaluated efficacy well focusing on improve potential including combination therapy with inhibitors (ICIs).

Язык: Английский

Процитировано

52

The role of microRNAs in the pathophysiology of human central nervous system: A focus on neurodegenerative diseases DOI
Delsuz Rezaee,

Fatemeh Saadatpour,

Nayyereh Akbari

и другие.

Ageing Research Reviews, Год журнала: 2023, Номер 92, С. 102090 - 102090

Опубликована: Окт. 11, 2023

Язык: Английский

Процитировано

44

Long non-coding RNAs (lncRNAs); roles in tumorigenesis and potentials as biomarkers in cancer diagnosis DOI
Sajad Najafi, Seyyed Hossein Khatami, Marjan Khorsand

и другие.

Experimental Cell Research, Год журнала: 2022, Номер 418(2), С. 113294 - 113294

Опубликована: Июль 20, 2022

Язык: Английский

Процитировано

61

The emerging roles and potential applications of circular RNAs in ovarian cancer: a comprehensive review DOI
Sajad Najafi

Journal of Cancer Research and Clinical Oncology, Год журнала: 2022, Номер 149(5), С. 2211 - 2234

Опубликована: Сен. 2, 2022

Язык: Английский

Процитировано

53

Recent insights into the roles of circular RNAs in human brain development and neurologic diseases DOI
Sajad Najafi, Seyed Mohsen Aghaei Zarch, Jamal Majidpoor

и другие.

International Journal of Biological Macromolecules, Год журнала: 2022, Номер 225, С. 1038 - 1048

Опубликована: Ноя. 18, 2022

Язык: Английский

Процитировано

42

Extracellular vesicle–based drug delivery in cancer immunotherapy DOI Open Access
Sajad Najafi, Jamal Majidpoor, Keywan Mortezaee

и другие.

Drug Delivery and Translational Research, Год журнала: 2023, Номер 13(11), С. 2790 - 2806

Опубликована: Июнь 1, 2023

Язык: Английский

Процитировано

38

microRNA-382 as a tumor suppressor? Roles in tumorigenesis and clinical significance DOI
Mehdi Fattahi,

Saeid Shahrabi,

Fatemeh Saadatpour

и другие.

International Journal of Biological Macromolecules, Год журнала: 2023, Номер 250, С. 125863 - 125863

Опубликована: Июль 18, 2023

Язык: Английский

Процитировано

38

The role of microRNA-185 in the pathogenesis of human diseases: A focus on cancer DOI Open Access
Safoora Pordel,

Motahare Khorrami,

Fatemeh Saadatpour

и другие.

Pathology - Research and Practice, Год журнала: 2023, Номер 249, С. 154729 - 154729

Опубликована: Авг. 16, 2023

Язык: Английский

Процитировано

30

Circular RNAs and cervical cancer: friends or foes? A landscape on circRNA-mediated regulation of key signaling pathways involved in the onset and progression of HPV-related cervical neoplasms DOI Creative Commons

Emad Heydarnia,

Zahra Dorostgou,

Neda Hedayati

и другие.

Cell Communication and Signaling, Год журнала: 2024, Номер 22(1)

Опубликована: Фев. 10, 2024

Abstract Cervical cancer (CC) is a common gynecologic malignancy, accounting for significant proportion of women death worldwide. Human papillomavirus (HPV) infection one the major etiological causes leading to CC onset; however, genetic, and epigenetic factors are also responsible disease expansion. Circular RNAs (circRNAs), which known as particular subset non-coding RNA (ncRNA) superfamily, with covalently closed loop structures, have been reported be involved in progression diverse diseases, especially neoplasms. In this framework, abnormally expressed circRNAs strong correlation pathogenesis through regulating substantial signaling pathways. Also, these molecules can considered promising biomarkers therapeutic targets diagnosis/prognosis treatment, respectively. Herein, we first review key molecular mechanisms, including Wnt/β-catenin, MAPK, PI3K/Akt/mTOR pathways, well angiogenesis metastasis, by interfere development. Then, diagnostic, prognostic, potentials ncRNA will highlighted depth.

Язык: Английский

Процитировано

13

Signaling pathways governing glioma cancer stem cells behavior DOI
Ava Nasrolahi, Shirin Azizidoost, Klaudia Radoszkiewicz

и другие.

Cellular Signalling, Год журнала: 2022, Номер 101, С. 110493 - 110493

Опубликована: Окт. 11, 2022

Язык: Английский

Процитировано

29